Systemic hypoxia inhibits T cell response by limiting mitobiogenesis via matrix substrate-level phosphorylation

Amijai Saragovi1, Ifat Abramovich2, Ibrahim Omar1

  • 1The Lautenberg center for Immunology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University Medical School, Jerusalem, Israel.

Elife
|November 23, 2020
PubMed

Insights

Systemic oxygen restriction impairs CD8+ T cell antiviral immunity by inhibiting mitochondrial energy production. Restoring oxygen levels or metabolic function can rescue this immune suppression, offering new strategies for treating viral infections in COPD.

Area of Science:

  • Immunology
  • Cellular Biology
  • Respiratory Medicine

Background:

  • Systemic oxygen restriction (SOR) is common in conditions like COPD, increasing viral infection susceptibility.
  • The impact of SOR on T cell immunity, particularly CD8+ T cells, is not well understood.

Purpose of the Study:

  • To investigate the effects of hypoxia on CD8+ T cell mitochondrial biogenesis and antiviral function.
  • To identify mechanisms by which low oxygen impairs T cell immunity and explore potential rescue strategies.

Main Methods:

  • Activated mouse CD8+ T cells were studied under hypoxic conditions.
  • Mitochondrial biogenesis and ATP production were assessed.
  • Antiviral responses were evaluated in vivo.
  • TCA cycle stimulation and oxygen exposure were used as rescue interventions.

Main Results:

  • Hypoxia significantly impaired mitochondrial biogenesis and ATP production in CD8+ T cells.
  • Low oxygen levels diminished the in vivo antiviral response of CD8+ T cells.
  • TCA cycle re-stimulation rescued ATP production and partially restored T cell function.
  • Brief exposure to atmospheric oxygen pressure restored the antiviral capacity of CD8+ T cells in vivo.

Conclusions:

  • Hypoxia detrimentally affects mitochondrial biogenesis in activated CD8+ T cells, compromising their antiviral function.
  • Metabolic interventions, including TCA cycle stimulation and oxygen re-exposure, can overcome hypoxia-induced immune suppression.
  • These findings suggest novel therapeutic approaches for viral infections in patients with COPD and other conditions involving systemic oxygen restriction.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
17.4K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.7K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
19.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K